Back to Agenda
HOW TO OPTIMIZE DRUG DEVELOPMENT UP TO APPROVAL AND BEYOND - PARALLEL BREAKOUT SESSIONS WITH CASE STUDIES
Session Chair(s)
Martine Dehlinger-Kremer, PhD
Vice President Scientific Affairs, Pediatric Subject Matter Expert
ICON Plc, Germany
Have an account?